Prosetta Biosciences is a biotechnology company focused on developing novel small-molecule antiviral therapeutics based on Cell-Free Protein Synthesizing Systems (CFPSS).
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/31/2015 | Series D | $31.1MM | $xx.xx | $378.68MM | Takeda Ventures, Alger | |
Price per Share
$xx.xx
Shares Outstanding
6,910,395
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Takeda Ventures, Alger
|
||||||
07/15/2012 | Series C | $15.75MM | $xx.xx | $114.43MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,500,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Undisclosed Investors
|
||||||
09/15/2008 | Series B | $7.4MM | $xx.xx | $95.33MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,850,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Undisclosed Investors
|
||||||
05/18/2007 | Series AAA | $2.25MM | $xx.xx | $74.7MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
750,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Undisclosed Investors
|
||||||
05/18/2007 | Series AA | $6.12MM | $xx.xx | $74.7MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
9,000,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Undisclosed Investors
|
||||||
05/18/2007 | Series A | $1.02MM | $xx.xx | $74.7MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,700,000
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Undisclosed Investors
|